Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2023

Conditions
Non Small Cell Lung CancerNSCLCNon-small Cell Lung CancerNon-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage ⅢANSCLC Stage IIIBNSCLC, Stage IIIA
Interventions
DIETARY_SUPPLEMENT

Impact® Advanced Recovery

The intervention drink Impact® will be ingested every two weeks since usually chemotherapy is delivered concurrently with radiation therapy in 2 week cycles. For patients who are placed on weekly or every 4 weeks chemotherapy dosing schedules, the treatment and control supplements will still be given every two weeks.

DIETARY_SUPPLEMENT

Boost® High Protein

The control supplement drink Boost® will be ingested every two weeks since usually chemotherapy is delivered concurrently with radiation therapy in 2 week cycles. For patients who are placed on weekly or every 4 weeks chemotherapy dosing schedules, the treatment and control supplements will still be given every two weeks.

RADIATION

Radiation Therapy

Standard of Care: Weekly radiation therapy as already planned for each participant, at Moffitt clinic visits.

DRUG

Chemotherapy

Standard of Care: Chemotherapy as already planned for each participant.

OTHER

Quality of life (EORTC-QLQ-30)

Participants will undergo pre- and post-treatment assessments.

OTHER

Evaluation of Cognitive Function (FACT-Cog, v. 3.0)

Participants will undergo pre- and post-treatment assessments.

OTHER

Mindfulness Questionnaire (FFMQ)

Participants will undergo pre- and post-treatment assessments.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nestle Health Science

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER